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Abstract. This paper summarises the information given
on the 1985 EDTA Registry centre questionnaire which
was returned by 82% of 1959 known dialysis and trans-
plant units in 33 European countries. Trends in the use of
different forms of renal replacement therapy are dis-
cussed, and attention drawn to the discrepancy between
the EDTA centre and individual patient questionnaires as
a source of demographic information on dialysis and
transplantation. The results of special questions on dia-
lyser re-use, dialysis equipment, AIDS, and hepatitis are
presented, and information obtained from the special
paediatric section of the centre questionnaire is also given.
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Introduction
The Registry of the European Dialysis and Transplant
Association—European Renal Association (EDTA
Registry) collects data from two sources: an individual
patient questionnaire and a centre questionnaire. The
centre questionnaire requests summary data on a unit's
activity during the year, and also includes questions on
topics of special interest. In contrast to the patient ques-
tionnaire, the format of the centre questionnaire is varied
from year to year around a basic core of questions. These
core questions relate to the demography of dialysis and
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Table 1. Summary of centres known to the EDTA Registry in 1985. the
number per million population (PMP) and the proportion (per cent)
returning the 1985 centre questionnaire. Population figures arc taken
from the most recent World Bank Atlas [3]
Report from the EDTA Registry
Table 2. Summary of new patients accepted onto renal replacement
therapy during 1985 in Europe: based on data from the centre question-
naire, supplemented by National Keymen. Both the absolute number of
new patients and the acceptance rate per million population are given for
each country
Country Population
in millions
Known
centres
Known
centres
PMP
% Replied
Country Data
available
% centres
New patients
in 1985
Per million
population
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed Rep Germany
Finland
France
German Dem Rep
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
21.265
7.527
9.856
8.960
0.665
15.464
5.110
46.172
61.205
4.902
55.089
16.701
9.888
10.692
0.240
3.533
4.172
57.033
2.624
3.620
0.365
21.347
14.411
4.151
36.918
10.202
38.523
8.337
6.572
7.068
48.266
56.327
22.955
620.160
7
27
59
38
4
27
11
31
331
27
216
54
51
13
1
5
29
392
7
3
5
5
50
17
54
40
199
35
38
10
19
67
87
1959
0.3
3.6
6.0
4.2
6.0
1.7
2.2
0.7
5.4
5.5
3.9
3.2
5.2
1.2
4.2
1.4
7.0
6.9
2.7
0.8
13.7
0.2
3.5
4.1
1.5
3.9
5.2
4.2
5.8
1.4
0.4
1.2
3.8
3.2
85.7
100.0
91.5
97.4
100.0
100.0
100.0
61.3
77.0
100.0
89.8
100.0
62.7
100.0
100.0
100.0
100.0
67.3
14.3
33.3
100.0
20.0
82.0
100.0
94.4
82.5
89.4
97.1
97.4
100.0
84.2
94.0
69.0
82.0
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed Rep Germany
Finland
France
German Dem Rep
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
85.7
85.2
91.5
89.5
100.0
96.3
81.8
38.7
63.1
85.2
72.2
100.0
54.9
92.3
0
100.0
75.9
54.6
14.3
33.3
80.0
100.0
90.0
76.5
79.6
67.5
78.9
77.1
86.8
80.0
63.2
100.0
56.3
70.6
81
522
610
291
32
361
221
318
3 635
220
2 366
534
573
202
0
170
245
2 670
0
24
19
78
711
149
385
497
1830
518
385
139
240
2 427
742
21 195
3.8
69.4
61.9
32.5
48.1
23.3
43.2
6.9
59.4
44.9
42.9
32.0
57.9
18.9
0.0
48.1
58.7
46.8
0.0
6.6
52.1
3.7
49.3
35.9
10.4
48.7
47.5
62.1
58.6
19.7
5.0
43.1
32.3
34.2
transplantation and include items such as the number of
new patients accepted for treatment and the number of
grafts performed.
Demographic information published by the Registry is
based on returns to both the individual patient and centre
questionnaires [1,2]. These sources often yield different
figures. The reasons for this are varied and include incom-
plete registration of individual patients, a discrepancy
between the number of centres which return centre and
patient questionnaires, and some double reporting on the
centre questionnaire. Demographic information based on
returns to the centre questionnaire is usually available
prior to that derived from the patient questionnaire.
Both patient and centre questionnaires are mailed at
the end of each year. Centres which do not return the
centre questionnaire by a specified date are sent a
reminder, and if they fail to respond, an attempt is made
to ascertain the missing information through National
Keymen, who work closely with the Registry. Table 1
summarises centres known to the Registry in each of the
33 countries which report, the number per million popu-
lation, and the proportion returning the 1985 centre ques-
tionnaire. Units which returned the questionnaire did not
necessarily provide all the information requested.
This article is based on data provided in the 1985 centre
questionnaire, and the returns, shown in Table 1, have in
some cases been supplemented by information from
National Keymen (Tables 2-5).
Demography of Dialysis and Transplantation in
1985
Table 2 summarises numbers of new patients accepted
onto renal replacement therapy during 1985. The Table
shows the proportion of centres for which data were avail-
able either from the centre questionnaire or through the
EDTA Registry Centre Survey. 1985
Table 3. Total number ofpatients alive on different forms of renal replacement therapy
on 31 December 1985: based on data from the centre questionnaire, supplemented by
information from National Keymen. Total number ofpatients alive on renal replace-
ment therapy at the end of 1985 is shown as an absolute number and is also expressed
per million population
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Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed Rep Germany
Finland
France
German Dem Rep
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Patients on treatment at 31
Hosp.
HD
235
1 391
2 234
881
122
878
467
927
13 835
265
9918
1676
1 101
453
12
229
858
11674
15
62
83
203
1870
199
1055
1823
7 872
823
1015
282
774
1923
2713
67 868
Home
HD
3
47
106
50
0
2
61
0
1285
2
2157
0
95
0
0
22
48
763
0
0
5
0
155
4
0
0
290
75
169
0
0
2033
73
7445
IPD
0
2
8
1
0
5
43
97
121
6
150
9
0
38
0
1
65
100
0
0
0
0
0
5
50
1
50
22
1
1
79
52
79
986
December 1985
CAPD With
35
22
152
2
0
2
182
14
369
182
856
4
188
5
4
50
218
1250
0
0
0
0
440
24
15
3
545
231
276
15
12
2373
69
7538
fund.
graft
0
461
111
23
0
316
217
120
3 028
785
2 964
588
136
161
0
329
286
1347
0
0
13
0
1 694
709
384
187
2 098
1 506
1057
0
104
5 773
225
25 288
Total
273
1923
3 277
957
122
1203
970
1 158
18 638
1 240
16045
2 277
1520
657
16
631
1475
15 134
15
62
101
203
4 159
941
1 504
2014
10 855
2 657
2518
298
969
12 154
3 159
109 125
Per
mill.
pop.
12.8
255.5
332.5
106.8
183.5
77.8
189.8
25.1
304.5
253.0
291.3
136.3
153.7
61.4
66.7
178.6
353.5
265.4
5.7
17.1
276.7
9.5
288.6
226.7
40.7
197.4
281.8
318.7
383.1
42.2
20.1
215.8
137.6
176.0
National Keymen. For centres which returned the centre
questionnaire but failed to complete the question on new
patients, the data have been treated as missing. This is not
always correct, as some of these centres may indeed have
had no patients commencing renal replacement therapy
(RRT) in 1985. The numbers of new patients accepted
onto treatment in 1985 are shown both as absolute
numbers and expressed per million population [3]. The
acceptance rate for new patients in 1985 exceeded 60 per
million population in Austria, Belgium and Sweden.
The total number ofpatients alive on different forms of
renal replacement therapy at the end of 1985 is shown by
country in Table 3. The Table also gives the total number
of patients alive on treatment per million population on
31 December 1985.
OTHER COUNTRIES
S LARCEST COUNTRIES
'85
Fig. 1. Numbers ofpatients on haemodialysis 1981-1985, as reported on
the centre questionnaire. Results for five large Western European
countries, the Federal Republic of Germany, France, Italy, Spain and
the United Kingdom, have been shown separately.
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Table 4. Number of patients alive on special formsofdialysis/haemofiltralionon31 December 1985:
based on data from the centre questionnaire
Report from the EDTA Registry
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed Rep Germany
Finland
France
German Dem Rep
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Haemodialysis/haemofiltration
Bicarb.
HD
0
142
886
0
0
5
44
0
2 657
107
2 471
293
216
6
0
6
30
3 035
0
0
16
10
288
7
36
0
779
38
154
0
11
164
56
11457
Haemo-
filtration
0
41
76
52
0
53
23
21
799
1
201
47
88
71
0
0
26
484
0
0
1
0
34
5
7
0
275
30
54
60
15
13
87
2564
Haemodia-
filtration
21
20
79
6
0
32
36
36
324
0
163
0
38
0
0
0
128
383
0
0
7
0
9
4
86
0
189
6
26
69
20
85
40
1807
HD+Haemo-
perfusion
25
3
1
9
14
6
1
18
103
0
6
25
5
20
0
0
25
43
0
0
0
0
6
0
2
0
212
1
17
0
0
0
56
598
Peritoneal dial.
CCPD
0
1
23
1
0
0
0
0
14
0
40
0
0
0
0
0
0
10
0
0
0
0
1
0
I
1
19
3
2
0
0
138
3
257
PD + HD
1
13
1
0
0
0
2
1
33
0
5
0
0
10
0
0
0
4
0
0
0
0
0
0
9
0
4
0
1
0
9
11
7
111
The growth of the number of patients treated by
haemodialysis in the years 1981-1985 is shown in
Fig. 1. Results for the five largest countries reporting
to the Registry, the Federal Republic of Germany,
France, Italy, Spain and the United Kingdom, are shown
separately.
Table 4 shows the number of patients on special forms
of dialysis or haemofiltration on 31 December 1985. The
number of patients alive on bicarbonate haemodialysis
increased to 11 457 compared to 7534 reported on the
1984 centre questionnaire [2]. The numbers on haemofil-
tration, haemodiafiltration and CCPD also increased.
For the first time, the 1985 centre questionnaire requested
information on patients treated by haemodialysis plus
haemoperfusion, and the results are given in Table 4.
The proportion of patients on haemodialysis treated by
haemofiltration or bicarbonate haemodialysis increased
between 1982 and 1985 (Fig. 2). The rise was particularly
notable for bicarbonate haemodialysis. Figure 3 shows
that whereas the proportion of patients treated by home
haemodialysis declined from 1981 to 1985, that on CAPD
increased. This trend was analysed separately for five
selected European countries, the United Kingdom,
France, the Federal Republic of Germany, Italy and
Spain, and the results are given in Fig. 4. The proportion
of patients treated by CAPD between 1981 and 1985 rose
most dramatically in the United Kingdom.
Transplant activity in 1985, based on data from the
centre questionnaire, is shown in Table 5. Wherever
possible, missing information was collected through
National Keymen. The use of grafts from living donors
contributed substantially to the high transplantation rate
in Scandinavian countries: in Norway, 50% of all first
grafts performed in 1985 came from that source.
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Fig. 2. The proportion of patients on haemodialysis on 31 December of
each of the years 1981 1985 treated by haemofiltration and bicarbonate
haemodialysis. as reported on the centre questionnaire.
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Rg. 3. The proportion of all patients on dialysis on 31 December of each
of the years 1981 -1985 treated by home haemodialysis. continuous
ambulatory peritoneal dialysis and intermittent peritoneal dialysis, as
reported on the centre questionnaire.
Re-use of Dialysers and Dialysis Equipment
Information on use and re-use of individual dialysers is
collected on the patient questionnaire. However, the 1985
centre questionnaire included a question on re-use tech-
niques, the results of which are summarised in Table 6.
The proportion of centres which replied to the question,
s
-I
so
40
30-
20-
10-
oJ
81 82 83 84 85
Fig. 4. The proportion of all dialysis patients treated by home haemodi-
alysis and continuous ambulatory peritoneal dialysis on 31 December of
each of the years 1981 1985 as reported on the centre questionnaire in
five selected European countries. UK, United Kingdom: F. France;
FRG. Federal Republic of Germany: I. Italy: E. Spain.
.the proportion of these which reported re-use, and the
techniques employed, are shown. Of the 78.9% of known
centres which responded to the question, 11.7% reported
re-use in 1985. Some centres indicated more than one
re-use technique.
A question on dialysis equipment, included on the 1983
centre questionnaire, was repeated in 1985 [4]. The results
of the latest enquiry are shown in Table 7. Results are
given by country and include the proportion of centres
which replied to the question, together with the numbers
of the different types of dialysis machines. The proportion
of these machines in homes is also indicated.
Transplantation
An important part of the centre questionnaire is devoted
to transplant information (Table 5). A question on wait-
ing lists for cadaver transplants included on the 1984
centre questionnaire was widely misunderstood, and a
revised version was therefore included for a second time in
1985. The results are shown in Table 8, which gives the
proportion of patients registered on a waiting list for a
cadaver transplant in 1985 as reported by.dialysis centres.
Although the differences between countries were remark-
able, they did not have a clear relationship to the overall
transplantation rate.
For the first time, the 1985 centre questionnaire
included a question on the proportion of patients on
waiting lists for a cadaver transplant who were highly
sensitised ('most recent serum reacting with more than
480
Table 5. Transplant activity in 1985 based on data from the centre questionnaire, supplemented by infor-
mation from National Keymen. The Table gives the total number ofgrafts performed in 1985 as an absolute
number and also expressed per million population (PMP). The total numbers ofgrafts performed in all years
until the end of 1985 are shown in the extreme right-hand column
Report from the EDTA Registry
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed Rep Germany
Finland
France
German Dem Rep
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Cadaver
1st
graft
1
135
216
9
0
127
—
0
973
107
679
161
9
58
0
40
59
335
0
0
7
0
—
76
142
94
739
197
117
0
6
1059
35
5381
Pats.
< I 5
0
10
21
0
0
2
5
0
67
2
65
7
0
1
0
3
10
14
0
0
0
0
20
1
5
2
36
3
2
0
0
105
0
381
Total
Living Donor
1st
CAD grafts graft
1
160
248
9
0
143
195
0
1160
134
833
170
13
64
0
52
75
355
0
0
7
0
289
99
147
99
825
262
203
0
7
1367
35
6952
0
7
40
0
0
0
9
56
61
7
24
4
9
7
0
20
30
17
0
0
2
0
15
76
1
0
49
57
7
0
58
178
33
767
Pats.
<15
0
2
5
0
0
0
0
1
8
0
5
0
1
1
0
5
1
2
0
0
0
0
3
2
1
0
10
8
1
0
0
7
1
64
Total
LD grafts
0
7
42
0
0
I
13
57
63
7
36
4
18
8
0
20
39
19
0
0
2
0
34
80
4
0
55
65
10
0
58
188
36
866
Total*
All
grafts
1
167
290
9
0
144
208
57
1274
141
1157
174
31
72
0
72
114
374
0
0
9
0
323
179
151
99
956
331
213
0
65
1555
71
8237
PMP
<0.1
22.2
29.4
1.0
0.0
9.3
40.7
1.2
20.8
28.8
21.0
10.4
3.1
6.7
0.0
20.4
27.3
6.6
0.0
0.0
24.7
0.0
22.4
43.1
4.1
9.7
24.8
39.7
32.4
0.0
1.3
27.6
3.1
13.3
Total
grafts
performed
all years
1
1 196
3 354
28
0
1 120
2 376
168
7 422
1661
7067
1522
296
407
0
664
628
2 373
0
0
18
0
—
1433
746
296
3919
3781
2 285
0
467
13 575
447
57 250
•Data from centre questionnaire supplemented from other sources
— Data unavailable
80% of a random donor panel'). Table 9 shows the
number of patients on a waiting list for a cadaver trans-
plant as reported by transplant centres, and the pro-
portion of these highly sensitised. Overall, 10.8% of
patients fell into this particular category, where it is
difficult to find a suitable graft.
Cyclosporin (CyA) was used as prophylactic immuno-
suppressioh after renal transplantation in approximately
50% of all transplant centres in 1983. In 1984, this figure
increased to 60%, a proportion which did not change in
1985 (Fig. 5). Dosages of CyA used in the first week after
transplantation have fallen within the last year (Fig. 6).
An initial dosage of 14-15 mg/kg per day was by far the
most frequently reported in 1984. and less than 10 mg/kg
per day was given in only a small proportion of centres. In
contrastjn 1985, an initial dosage of 10-11 mg/kg per day
was as frequently used as the former 'standard' dosage of
14-15 mg/kg per day, and more than one-third of all
transplant centres reported initial dosages below lOmg/
kg per day.
Figure 7 shows the regimens most commonly used dur-
ing the first week after grafting by units which reported
use of cyclosporin in 1985. Only 5% of these centres used
CyA alone, i.e. without any other immunosuppressive
drug. By far the most common regime was a combination
of CyA with steroids, used by 59% of all transplant
centres. CyA was not used in the first week in 17% of those
units reporting use of the drug in 1985, which suggests
EDTA Registry Centre Survey. 1985
Table 6. The proportion of centres which reported re-using dialysers in 1985. as reported on the centre
questionnaire. The Table gives the number of centres which replied to this question, and the technique used
by centres which reported re-use
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Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed Rep Germany
Finland
France
German Dem Rep
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Re-use of dialysers
% centres
replied
85.7
88.9
93.2
92.1
100.0
96.3
100.0
54.8
74.0 .
92.6
85.7
98.2
58.8
92.3
100.0
100.0
89.7
63.5
14.3
33.3
100.0
100.0
82.0
100.0
90.7
77.5
87.4
94.3
94.7
100.0
84.2
88.1
67.8
78.9
Centres
re-using dial.
%
0
0
14.6
91.4
0
3.9
9.1
11.8
3.3
0
13.0
0
0
8.3
0
0
11.5
5.2
0
0
20.0
0
0
11.8
71.4
32.3
6.9
0
19.4
0
0
33.9
1.7
11.7
n
0
0
8
32
0
1
1
2
8
0
24
0
0
1
0
0
3
13
0
0
1
0
0
2
35
10
12
0
7
0
0
20
1
181
Techniques used (« centres)
Manual
0
0
2
21
0
0
0
I
4
0
18
0
0
0
0
0
2
8
0
0
0
0
0
2
34
7
2
0
5
0
0
14
0
120
Re-use cycle on
proportionating
machine
0
0
3
3
0
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
1
0
0
0
5
0
0
0
2
0
0
5
0
21
Separate
automatic
machine
0
0
4
6
0
I
1
0
4
0
3
0
0
0
0
0
1
3
0
0
0
0
0
0
0
7
9
0
1
0
0
7
0
47
that they either restricted its use for special patients or
started the drug after the first week post-transplant,
probably to avoid nephrotoxic effects in the early and
vulnerable postoperative period. The use of 'triple drug
therapy' (combination of CyA, azathioprineand steroids)
was reported by 15% of centres as the most common form
of immunosuppression during the first week after renal
transplantation in 1985. Almost half (48%) of centres
reported use of 'triple drug therapy' for prophylactic
immunosuppression in one or more patients during 1985.
AIDS and Hepatitis
So far, few reports exist about infection with human
immunodeficiency virus (HTLV-III/LAV) in patients on
renal replacement therapy. On the 1985 centre question-
naire, an enquiry was made about current policies in test-
ing for HTLV-III/LAV antibodies and cases of acquired
immune deficiency syndrome (AIDS). Testing for
HTLV-III/LAV antibodies was reported in 'most or all
patients' in 30% of all centres which answered this
enquiry, while in 13%, only 'selected patients' were tested
(Table 10). No testing for HTLV-III/LAV antibodies was
reported by 57% of units. Practice on testing for anti-
bodies differed markedly from country to country and
was not obviously influenced by the number of deaths
attributed to AIDS in patients with end-stage renal failure
(Table 10). In Sweden, where no AIDS deaths were
reported to the Registry in patients with end-stage renal
failure, two-thirds of all centres tested for anti-HTLV-
III/LAV, whereas in Italy, where two AIDS deaths were
482 Report from the EDTA Registry
Table 7. Summary of dialysis equipment in use in Europe at the end of 1985. The numbers of haemodialysis. haemofiltration and peritoneal dialysis
machines are shown, together with the proportion of these in homes
Country-
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed Rep Germany
Finland
France
German Dem Rep
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Centres
replied %
86
85
93
87
100
93
91
52
75
96
87
91
59
92
100
100
97
64
14
33
100
100
80
100
93
80
86
94
95
100
63
85
64
78
Haemodialysis machines
VCU
n
9
180
415
96
0
27
49
40
2880
37
1921
9
70
2
0
15
161
881
3
2
5
0
273
69
66
169
935
75
167
26
29
842
288
9741
BIC
n
0
67
237
8
0
6
23
2
1332
55
879
57
24
2
0
2
40
1122
0
2
9
2
157
10
23
14
359
28
85
0
2
191
24
4762
Vary Na
»
0
265
262
142
0
36
32
43
4 549
59
1682
270
159
18
0
2
130
2 702
3
0
5
0
183
52
117
107
1242
149
154
31
42
1008
369
13813
Total
n
80
328
705
208
25
221
214
163
6 729
206
4 067
409
311
93
7
85
317
5 003
6
10
44
21
658
178
355
516
2 900
419
523
104
123
3364
1899
31072
Home
%
3.8
14.6
8.2
0
0
0.9
23.8
0
16.9
1.0
43.6
0
0
0
0
28.2
14.2
14.5
0
0
11.4
0
7.3
2.8
0
0
9.3
11.2
28.9
0
0
57.4
2.4
20.5
Haemofiltration
machines
n
0
20
94
9
0
8
7
11
459
2
114
15
2
1
0
0
I
209
0
0
6
0
26
7
3
0
78
20
15
0
2
23
24
1156
Home
%
0
0
9.6
0
0
0
0
0
3.5
0
12.3
0
0
0
0
0
0
0.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4.2
3.6
Peritoneal
dialysis machines
n
6
5
17
2
0
4
31
6
192
5
202
16
12
7
0
5
4
357
0
1
1
0
21
1
14
9
104
38
70
2
1
185
8
1326
Home
%
16.7
20.0
17.7
0
0
0
22.6
0
7.8
0
15.4
37.5
0
0
0
0
0
5.0
0
0
0
0
9.5
0
7.1
0
0
2.6
2.9
0
0
17.3
12.5
9.1
Total
n
86
353
816
219
25
233
252
180
7 380
213
4 383
440
325
101
7
90
322
5 569
6
11
51
21
705
186
372
525
3082
477
608
106
126
3572
1931
33 554
Home
%
4.7
13.9
8.6
0
0
0.9
23.0
0
15.9
0.9
41.5
1.4
0
0
0
26.7
14.0
13.3
0
0
9.8
0
7.1
2.7
0.1
0
8.7
10.1
25.2
0
0
54.9
2.4
19.5
VCU. volume controlled ultrafiltration monitor; BIC. bicarbonate dialysate module: Vary Na, variable dialysate sodium concentration
reported, only one-third of centres reported testing. In
Norway, unlike Sweden, few 'selected' patients were
tested in 1985.
Figure 8 shows the number of new cases of hepatitis B
diagnosed in the years 1980-1985 in both patients and
staff, expressed per thousand patients on hospital haemo-
dialysis at the end of each year. The ratio in patients
declined rapidly from about 44 per thousand in 1980 to 24
per thousand in 1982, and subsequently remained stable.
A decline in the ratio for staff was also observed in this
period. However, large variations in the frequency of
hepatitis were still found between countries (Table 11).
The ratio of cases of hepatitis B per thousand alive on
hospital haemodialysis in 1985 exceeded 100 in Czecho-
slovakia, Egypt, the German Democratic Republic, and
Tunisia. Similarly, high rates for cases among staff were
observed in Algeria, the German Democratic Republic,
and Poland.
Paediatric Information
Each year, the centre questionnaire contains a section
requesting information on the treatment of children by
dialysis and transplantation. Table 12 shows new paedia-
tric patients accepted for renal replacement therapy in
1985 by type of centre, self-defined as specialised for pae-
diatric patients or not, on the centre questionnaire. The
total number of new patients include those taken on from
foreign countries who were not included in the calculation
EDTA Registry Centre Survey. 1985
Table 8. Proportion of dialysis patients on a waiting list for cadaver
transplant as reported by dialysis centres on the 1985 centre question-
naire
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Country' Per cent
patients
Country
patients
Per cent
no-
ctrrt
camras
40-
Algeria 22.0
Austria 30.6
Belgium 13.2
Bulgaria 20.8
Cyprus 38.5
Czechoslovakia 52.8
Denmark 25.4
Egypt 1.4
Fed. Rep Germany 20.3
Finland 45.3
France 15.4
German Dem Rep 28.4
Greece 16.8
Hungary 58.1
Iceland 0
Ireland 46.0
Israel 16.8
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
17.7
6.7
0
25.8
8.6
31.0
41.4
65.8
25.1
43.9
25.9
21.7
21.8
35.1
41.5
32.4
25.6
Fig. 5. The proportion of transplant centres which reported use of
cyclosporin for prophylactic immunosuppression on the centre ques-
tionnaire in 1983.1984 and 1985.
30-
Per
cent 20-
centres
10-
Table 9. The number of patients on a waiting list for a cadaver trans-
plant, and the proportion highly sensitised as reported by transplant
units on the 1985 centre questionnaire
4-5 10-11 12-13 14-B 16-17
mg/kg/day
Fig. 6. Frequency distribution of oral dose of cyclosporin 'most com-
monly used' in the first week post-transplant, as reported by transplant
centres on the 1984 and 1985 centre questionnaire.
Country Number on
waiting list
Per cent highly
sensitised
Algeria 32
Austria 515
Belgium 378
Bulgaria 486
Cyprus 0
Czechoslovakia 530
Denmark 84
Egypt 3
Fed Rep Germany 4 054
Finland 186
France 2 347
German Dem Rep 447
Greece 110
Hungary 464
Iceland 0
Ireland 147
Israel 127
Italy 1928
Lebanon 0
Libya 0
Luxembourg 22
Morocco 0
Netherlands 659
Norway 110
Poland 1448
Portugal 677
Spain 4 284
Sweden 358
Switzerland 173
Tunisia 13
Turkey 326
United Kingdom 2 675
Yugoslavia 1089
Total Registry 23 672
25.0
15.2
9.3
0.8
0
10.6
23.8
0
4.7
22.0
17.9
21.0
8.2
11.2
0
19.1
14.2
9.2
0
0
4.6
0
19.9
11.8
7.5
4.7
10.7
10.3
19.8
0
3.1
13.5
12.4
10.8
CyA not used (17V
CyA 'Other
CyA • steroids
• All (15U
CyA alone (51)
CyA • steroids (591)
Fig. 7. Regimen most commonly used for prophylactic immunosuppres-
sion during the first week after transplant by centres which reported use
of cyclosporin (CyA) on the 1985 centre questionnaire. Aza, azathio-
prine.
Per 1000
pats, on
Hosp. HO
30-
20-
Patients
Staff
1980 1981 1982 1983 198* 1985
Year
Fig. 8. New cases of hepatitis B diagnosed in patients and staffin each of
the years 1980-1985, expressed per thousand patients on hospital hae-
modialysis at the end of each year.
484
Table 10. Summary of information on AIDS provided on the 1985 centre questionnaire. The Table shows
practice of centres in testing for HTLV-III/LAV antibodies by country. Cases of AIDS and deaths from the
disease in patients on renal replacement therapy are also shown. The proportion of centres which responded
to the section on AIDS is given by country
Report from the EDTA Registry
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed Rep Germany
Finland
France
German Dem Rep
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Testing for AIDS (% centres)
No
testing
100
16
46
93
100
100
50
100
39
62
33
94
28
100
100
100
78
59
100
100
40
100
83
82
88
36
60
24
53
50
85
70
85
57
In selected
patients
0
8
6
0
0
0
0
0
18
12
15
6
3
0
0
0
19
9
0
0
20
0
10
18
0
9
31
3
17
13
0
22
9
13
In most or
all patients
0
76
48
7
0
0
50
0
43
27
52
0
69
0
0
0
4
32
0
0
40
0
8
0
12
55
10
74
31
38
15
8
6
30
Cases of AIDS (n)
Suspected
cases
0
8
3
0
0
0
0
0
22
0
31
5
0
0
0
0
6
13
0
0
0
0
1
0
0
0
11
0
2
0
0
9
16
127
Deaths
0
0
0
0
0
0
0
0
2
0
4
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
10
% Centres
replied
71.4
92.6
89.8
71.1
75.0
88.9
90.9
38.7
74.6
96.3
83.8
96.3
54.9
76.9
100.0
100.0
93.1
62.5
14.3
33.3
100.0
100.0
78.0
100.0
90.7
82.5
81.9
97.1
94.7
80.0
68.4
88.1
62.1
76.4
of acceptance rate per million child population (pmcp)
given in the Table.
Table 13 shows the numbers of patients aged less than
15 years alive on any form of dialysis/haemofiltration at
the end of 1985 by type of centre. The proportion of
these children treated in specialised paediatric centres
(self-defined on the centre questionnaire) is given.
Conclusions
In recent years the EDTA centre questionnaire has
become an increasingly important source of demographic
information about renal replacement therapy. It is poss-
ible to collect and analyse these questionnaires long
before data from the individual patient questionnaire
becomes available. Figures from the two sources often
vary, for reasons outlined above, with centre question-
naire data producing slightly higher numbers for patients
on renal replacement therapy than the patient question-
naire.
Active steps are taken to ascertain information on units
which do not return the centre questionnaire, through the
National Keymen. However, even these measures do not
produce complete coverage, and the shortfall in data
varies from country to country (Table 1). It is in the
mutual interest of the renal care community at large to
provide as comprehensive data as possible to the EDTA
Registry, and the Registration Committee therefore wel-
comes suggestions on how completeness and quality of
information may be improved.
EDTA Registry Centre Survey. 1985
Table 11. Hepatitis diagnosed in patients and staffin 1985 as reported on the centre questionnaire. The numbers of cases of
hepatitis Bare shown in absolute numbers and also expressed per thousand patients on hospital haemodialysis at the end of
the year. Numbers of cases of hepatitis A and hepatitis non-A non-B are also shown
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Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed Rep Germany
Finland
France
German Dem Rep
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Patients
HepB
18
44
38
16
2
105
0
96
68
0
89
184
9
17
0
0
4
144
0
1
4
3
3
0
89
51
96
0
1
30
54
6
212
1384
Cases/1000
pats on
Hosp. HD
76.6
33.0
17.8
18.2
16.4
119.6
0
103.6
5.0
0
•9.1
109.8
8.2
37.5
0
0
4.7
12.5
0
16.1
48.2
32.3
1.9
0
85.4
28.0
13.1
0
1.1
106.4
79.6
3.1
78.1
21.0
Hep A
0
0
2
0
0
7
0
1
2
1
4
4
2
0
0
0
1
0
0
0
0
0
2
0
0
2
3
0
0
0
2
0
21
54
Hep non-A
non-B
1
9
21
0
2
15
0
0
82
1
133
31
16
7
0
0
34
155
0
0
0
0
9
3
4
43
139
7
8
1
0
18
5
744
Stan-
Hep B
5
0
2
4
0
13
0
5
4
0
2
62
1
9
0
0
0
15
0
1
0
0
0
0
38
22
14
0
0
2
6
1
30
236
Cases/1000
pats on
Hosp. HD
21.3
0
0.9
4.5
0
14.8
0
5.4
0.3
0
2.0
37.0
0.9
19.9
0
0
0
1.3
0
16.1
0
0
0 •
0
36.5
12.1
1.9
0
0
7.1
8.8
0.5
11.1
3.6
Hep A
0
0
3
I
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
2
1
2
0
0
0
0
0
0
11
Hep non-A
non-B
0
0
2
1
0
!
0
1
5
0
4
5
0
1
0
0
1
9
0
0
0
0
0
0
1
0
5
0
1
0
0
0
1
38
Table 12. Number of new paediatric patients accepted onto renal replacement therapy in specialised (with
number of specialised units shown in brackets) and non-specialised centres in 1985. The Table is based on
information provided on the 1985 centre questionnaire and also shows the total number of new patients per
million child population (PMCP). The number of new patients from foreign countries is shown separately
and was not included in the calculation of the acceptance rate PMCP
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Patients in
specialised
centres
(n centres)
10(2)
0(0)
13(4)
3(1)
0(0)
5(2)
0(0)
0(0)
Patients
in non-
specialised
centres
I
6
0
0
0
2
9
8
Total
n patients
11
6
13
3
0
7
9
8
Patients
PMCP
1.2
3.5
5.2
1.0
0
1.9
9.0
0.5
Foreign
new
patients
0
1
3
1
0
0
0
0
Table 12 continued top of next page
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Table 12. (Continued)
Report from the EDTA Registry
Country
Fed Rep Germany
Finland
France
German Dem Rep
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Patients in
specialised
centres
(n centres)
45(14)
2(1)
79(17)
14(4)
3(1)
6(1)
0(0)
7(1)
5(3)
26(9)
0(0)
0(0)
0(0)
0(0)
21(4)
0(0)
27(7)
4(2)
20(8)
0(1)
6(3)
0(0)
0(1)
59(9)
11(2)
366(97)
Patients
in non-
specialised
centres
8
1
11
2
2
6
0
0
5
28
2
0
0
1
0
4
1
3
15
12
1
0
10
18
9
165
Total
n patients
53
3
90
16
5
12
0
7
10
54
2
0
0
1
21
4
28
7
35
12
7
0
10
77
20
531
Patients
PMCP
5.0
3.1
6.3
4.7
2.3
4.7
0
5.6
7.2
4.0
1.9
0
0
0.1
6.4
4.6
3.0
2.9
3.5
7.7
6.3
0
0.5
6.5
3.4
Foreign
new
patients
4
0
14
1
0
1
0
1
0
5
0
0
0
0
2
0
0
0
0
0
0
0
0
3
1
37
Table 13. The number of children on dialysis on 31 December 1985 shown by type of centre.
The Table is based on information provided on the 1985 centre questionnaire and also shows
the proportion of children dialysed in specialised paediatric centres
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed Rep Germany
Finland
France
German Dem Rep
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Children on dialysis on 31 December 1985
Specialised
centres
10
0
24
3
0
3
0
0
77
1
183
33
2
3
0
1
13
60
0
0
0
1 Non-specialised
centres
5
6
2
3
0
2
9
7
14
2
33
2
4
7
2
J
6
36
0
0
1
Total
15
6
26
6
0
5
9
7
91
3
216
35
6
10
2
4
19
96
0
0
1
% Treated
in specialised
centres
67
0
92
50
0
60
0
0
85
33
85
94
33
30
0
25
68
63
0
0
0
Table 13 continued top of next page
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Table 13. {Continued)
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Country
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Children on dialysis on 31 December 1985
Specialised
centres
0
41
0
39
19
43
0
14
0
4
96
16
685
Non-specialised
centres
0
0
1
4
9
32
3
1
1
10
31
13
249
Total
0
41
1
43
28
75
3
15
1
14
127
29
934
% Treated
in specialised
centres
0
100
0
91
68
57
0
93
0
29
76
55
73
This paper has summarised information obtained on
the 1985 EDTA centre questionnaire, and discussed
trends in renal replacement therapy: the growth in
numbers treated by haemodialysis (including the special
forms), the declining importance of home haemodialysis,
the growth of CAPD and the remarkable transplantation
rates achieved by some countries.
Where possible, comparisons have been made between
countries. Interpretation of the trends and differences
demonstrated is difficult because of the many economic,
social and medical factors that influence the pattern of
renal replacement services offered in different parts of
Europe. The data are presented in order that individual
countries may review their own performance and perhaps
learn from different patterns of care offered elsewhere.
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